Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age-Reference-Cited by-同舟云学术

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age

Published:2022-07 Issue:1 Volume:80 Page:1-18
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Böhm Michael,Butler Javed,Filippatos Gerasimos,Ferreira João Pedro^ORCID,Pocock Stuart J.,Abdin Amr,Mahfoud Felix^ORCID,Brueckmann Martina,Gollop Nicholas D.,Iwata Tomoko,Ponikowski Piotr,Wanner Christoph,Zannad Faiez,Packer Milton,Anker Stefan D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Zelniker;Lancet,2019

2. Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus;Kato;Circulation,2019

3. Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial;Fitchett;Circulation,2019

4. DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019

5. EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure With Preserved Ejection Fraction in the Elderly Population: Basic Mechanisms and Clinical Considerations;Canadian Journal of Cardiology;2024-08

2. Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes;World Journal of Diabetes;2024-07-15

3. Impact of SGLT2 Inhibitors on Very Elderly Population with Heart Failure with Reduce Ejection Fraction: Real Life Data;Biomedicines;2024-07-07

4. The effect of Empagliflozin on echocardiographic parameters in diabetic patients after acute myocardial infarction: A systematic review and meta-analysis with trial sequential analysis;Irish Journal of Medical Science (1971 -);2024-07-03

5. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis;The Lancet Diabetes & Endocrinology;2024-07